24 early-stage NJ companies to receive $75M from NOL Program
NJEDA said 24 early-stage technology and biotech companies were approved to participate in this year’s Net Operating Loss (NOL) Program.
Stay updated with breaking news from Electrocore Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NJEDA said 24 early-stage technology and biotech companies were approved to participate in this year’s Net Operating Loss (NOL) Program.
/PRNewswire/ -- The "Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials...
/PRNewswire/ -- DelveInsight's Spinal Non-Fusion Devices Market Insights and Forecast report provides the current and forecast Spinal Non-Fusion Devices...
/PRNewswire/ -- The "Transcutaneous Electrical Nerve Stimulation Market Research Report by Surgery Procedures, by Product, by End User, by Region - Global...
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Bioelectric Medicine Market 2020-2030 by Product Type, End User, and Region: Trend Forecast and...